{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T13:10:27Z","timestamp":1655298627532},"reference-count":30,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1586\/ehm.10.52","type":"journal-article","created":{"date-parts":[[2010,10,27]],"date-time":"2010-10-27T16:02:47Z","timestamp":1288195367000},"page":"543-549","source":"Crossref","is-referenced-by-count":4,"title":["Plasma cell leukemia: concepts and management"],"prefix":"10.1586","volume":"3","author":[{"given":"Michaela","family":"Liedtke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno C","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1002\/cncr.24700","volume":"115","author":"Ramsingh","year":"2009","journal-title":"Cancer"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.4"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12185-009-0288-3","volume":"89","author":"Jimenez-Zepeda","year":"2009","journal-title":"Int. J. Hematol."},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood.V93.3.1032","volume":"93","author":"Garc\u0131a-Sanz","year":"1999","journal-title":"Blood"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0889-8588(05)70125-8","volume":"13","author":"Blade","year":"1999","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"CIT0006","unstructured":"Mckenna RW, Kyle RA, Kuehl WMet al.Plasma cell neoplasms. In:World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NLet al.(Eds). IARC Press, Lyon, France 200\u2013213 (2008)."},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.leu.2401211","volume":"12","author":"Pellat-Deceunynck","year":"1998","journal-title":"Leukemia"},{"key":"CIT0008","author":"Kraj","year":"2010","journal-title":"Leuk. Res."},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood.V97.3.822","volume":"97","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1038\/sj.leu.2404403","volume":"20","author":"Fonseca","year":"2006","journal-title":"Leukemia"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00277-002-0480-5","volume":"81","author":"Vela-Ojeda","year":"2002","journal-title":"Ann. Hematol."},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2141.1994.tb05114.x","volume":"88","author":"Dimopoulos","year":"1994","journal-title":"Br. J. Haematol."},{"key":"CIT0013","doi-asserted-by":"crossref","unstructured":"Murthy V, Mwirigi A, Ward S, Rassam SMB. Rapid and excellent response to hyperCVAD, particularly with thalidomide, in plasma cell leukaemia and long term remissions following allogeneic stem cell transplantation. Presented at:American Society of Hematology 51stAnnual Meeting. New Orleans, LA, USA, 5\u20138 December 2009.","DOI":"10.1182\/blood.V114.22.4963.4963"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ajh.20272","volume":"78","author":"Saccaro","year":"2005","journal-title":"Am. J. Hematol."},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jjco\/hym037","volume":"37","author":"Kim","year":"2007","journal-title":"Jpn. J. Clin. Oncol."},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00277-005-0027-7","volume":"85","author":"Grassinger","year":"2006","journal-title":"Ann. Hematol."},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.leukres.2007.11.010","volume":"32","author":"Katodritou","year":"2008","journal-title":"Leuk. Res."},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/cncr.22700","volume":"109","author":"Musto","year":"2007","journal-title":"Cancer"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1757-1626-2-121","volume":"2","author":"Chan","year":"2009","journal-title":"Cases J."},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1080\/10428190802290660","volume":"49","author":"Al-Nawakil","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"CIT0021","unstructured":"Musto P, Valentini C, D\u2019Auria Fet al.Bortezomib-containing combinations as front-line therapy in primary plasma cell leukemia: a retrospective study from GIMEMA multiple myeloma and acute leukemia working parties. Presented at:European Hematology Association Annual Meeting. Barcelona, Spain, 9\u201313 June 2010."},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/10428190290006143","volume":"43","author":"Johnston","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/10428190601007570","volume":"48","author":"Petrucci","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.leukres.2008.03.013","volume":"32","author":"Musto","year":"2008","journal-title":"Leuk. Res."},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1080\/10428190701361851","volume":"48","author":"Benson","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"CIT0026","unstructured":"Musto P, D\u2019Auria F, Petrucci MTet al.Lenalidomide plus low dose dexamethasone as first line therapy in patients with primary plasma cell leukemia: planned interim analysis of a pilot study from the GIMEMA-Italian Myeloma Network. Presented at:European Hematology Association Annual Meeting. Barcelona, Spain, 9\u201313 June 2010."},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3324\/haematol.2009.013334","volume":"95","author":"Drake","year":"2010","journal-title":"Haematologica"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3324\/haematol.2009.021618","volume":"95","author":"Gertz","year":"2010","journal-title":"Haematologica"},{"key":"CIT0029","unstructured":"Mahindra A, Vesole D, Kalycio MEet al.Autologous hematopoietic stem cell transplantation (HCT) is a safe and effective treatment for primary plasma cell leukemia: the CIBMTR experience. Presented at:American Society of Hematology 51st Annual Meeting. New Orleans, LA, USA, 5\u20138 December 2009."},{"key":"CIT0030","unstructured":"Pagano L, Valentini CG, De Stefano Vet al.Primary plasma cell leukemia: results of a retrospective Italian multicentric survey. Presented at:American Society of Hematology 51st Annual Meeting. New Orleans, LA, USA, 5\u20138 December 2009."}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/ehm.10.52","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T19:36:10Z","timestamp":1636745770000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/ehm.10.52"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1586\/ehm.10.52"],"URL":"https:\/\/doi.org\/10.1586\/ehm.10.52","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}